Acuity Inc. (De)
AYINYSECIK 1144215TechnologyFiscal year ends Aug 31
Reports and events: 216 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2308:15 ET | 10-K | Annual reportPeriod 2026-08-31 | 0001144215-26-000052 |
| 2026-10-0107:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-26-000047 |
| 2026-09-2916:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-111917 |
| 2026-06-2507:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-26-000038 |
| 2026-06-2507:24 ET | 10-Q | Quarterly reportPeriod 2026-05-31 | 0001144215-26-000036 |
| 2026-05-1317:13 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-221945 |
| 2026-04-0207:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-26-000023 |
| 2026-04-0207:21 ET | 10-Q | Quarterly reportPeriod 2026-02-28 | 0001144215-26-000021 |
| 2026-01-2316:16 ET | 8-K | 5.07 Shareholder vote results | 0001144215-26-000015 |
| 2026-01-0807:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-26-000012 |
| 2026-01-0807:34 ET | 10-Q | Quarterly reportPeriod 2025-11-30 | 0001144215-26-000010 |
| 2025-12-1107:46 ET | DEF 14A | Proxy statementPeriod 2025-08-31 | 0001144215-25-000104 |
| 2025-10-2716:15 ET | 10-K | Annual reportPeriod 2025-08-31 | 0001144215-25-000082 |
| 2025-10-0107:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-25-000076 |
| 2025-06-2607:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-25-000061 |
| 2025-06-2607:18 ET | 10-Q | Quarterly reportPeriod 2025-05-31 | 0001144215-25-000059 |
| 2025-04-0307:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-25-000045 |
| 2025-04-0307:40 ET | 10-Q | Quarterly reportPeriod 2025-02-28 | 0001144215-25-000043 |
| 2025-03-1208:14 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-052542 |
| 2025-02-1317:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001144215-25-000032 |
| 2025-01-2416:15 ET | 8-K | 5.07 Shareholder vote results | 0001144215-25-000013 |
| 2025-01-0807:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-25-000010 |
| 2025-01-0807:26 ET | 10-Q | Quarterly reportPeriod 2024-11-30 | 0001144215-25-000008 |
| 2025-01-0616:27 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events | 0001193125-25-002182 |
| 2024-12-1208:03 ET | DEF 14A | Proxy statementPeriod 2024-08-31 | 0001144215-24-000112 |
| 2024-11-2717:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-266224 |
| 2024-10-2816:06 ET | 10-K | Annual reportPeriod 2024-08-31 | 0001144215-24-000085 |
| 2024-10-2409:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-242335 |
| 2024-10-0107:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-24-000074 |
| 2024-06-2707:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-24-000070 |
| 2024-06-2707:22 ET | 10-Q | Quarterly reportPeriod 2024-05-31 | 0001144215-24-000068 |
| 2024-04-0307:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-24-000046 |
| 2024-04-0307:17 ET | 10-Q | Quarterly reportPeriod 2024-02-29 | 0001144215-24-000044 |
| 2024-01-2616:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001144215-24-000015 |
| 2024-01-0907:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-24-000007 |
| 2024-01-0907:33 ET | 10-Q | Quarterly reportPeriod 2023-11-30 | 0001144215-24-000005 |
| 2023-12-1408:02 ET | DEF 14A | Proxy statementPeriod 2023-08-31 | 0001144215-23-000123 |
| 2023-10-2608:09 ET | 10-K | Annual reportPeriod 2023-08-31 | 0001144215-23-000090 |
| 2023-10-0407:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-23-000082 |
| 2023-06-2907:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-23-000071 |
| 2023-06-2907:36 ET | 10-Q | Quarterly reportPeriod 2023-05-31 | 0001144215-23-000069 |
| 2023-04-0407:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-23-000055 |
| 2023-04-0407:31 ET | 10-Q | Quarterly reportPeriod 2023-02-28 | 0001144215-23-000053 |
| 2023-01-3008:10 ET | 8-K | 5.07 Shareholder vote results | 0001144215-23-000039 |
| 2023-01-0907:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144215-23-000011 |
| 2023-01-0907:31 ET | 10-Q | Quarterly reportPeriod 2022-11-30 | 0001144215-23-000008 |
| 2022-12-1507:55 ET | DEF 14A | Proxy statementPeriod 2022-08-31 | 0001144215-22-000117 |
| 2022-11-1810:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001144215-22-000114 |
| 2022-10-2608:29 ET | 10-K | Annual reportPeriod 2022-08-31 | 0001144215-22-000097 |
| 2022-10-0407:42 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144215-22-000091 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:35 ET. Listed shows no prices and gives no investment advice.